Published in Gastroenterology on March 01, 1976
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis (REBALANCE-UC) | NCT03483246
Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 9.16
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Gut (2007) 4.21
Activation of nuclear factor kappa B inflammatory bowel disease. Gut (1998) 4.14
Trichuris suis therapy in Crohn's disease. Gut (2005) 4.05
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
An index of inflammatory activity in patients with Crohn's disease. Gut (1980) 2.62
Novel evidence-based systemic lupus erythematosus responder index. Arthritis Rheum (2009) 2.58
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci (2008) 2.38
Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut (1991) 2.24
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut (2005) 2.20
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity. Dig Dis Sci (2010) 2.18
Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut (1986) 2.17
Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut (1981) 2.00
Thromboembolism in inflammatory bowel disease: role of platelets. Gut (1993) 2.00
A controlled double blind study of azathioprine in the management of Crohn's disease. Gut (1995) 2.00
111Indium autologous leucocytes in inflammatory bowel disease. Gut (1983) 1.95
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood (2006) 1.95
Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo. Gut (2010) 1.92
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut (2005) 1.91
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol (1996) 1.89
Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med (2005) 1.88
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol (2007) 1.87
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Biol Blood Marrow Transplant (2009) 1.84
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol (2013) 1.83
Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut (1981) 1.77
Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut (2004) 1.77
6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut (1996) 1.76
Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut (1994) 1.70
Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound. Gut (1998) 1.64
Influence of inflammatory bowel disease on intestinal microflora. Gut (1978) 1.61
Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut (1992) 1.60
Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol (2006) 1.59
Reduced bone density in patients with inflammatory bowel disease. Gut (1997) 1.56
Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut (2003) 1.55
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54
Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol (2001) 1.54
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Early postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition. Scand J Gastroenterol (2012) 1.51
Cytokine production in patients with inflammatory bowel disease. Gut (1992) 1.50
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals. J Clin Pathol (1981) 1.49
Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease. Dig Dis Sci (2015) 1.49
Cytomegalovirus infection in inflammatory bowel disease is not associated with worsening of intestinal inflammatory activity. PLoS One (2014) 1.48
A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut (2006) 1.48
Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig Dis Sci (2007) 1.45
Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut (1986) 1.44
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol (2015) 1.44
Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. Gut (1981) 1.41
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol (2012) 1.40
Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ (1994) 1.38
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease. Gut (2004) 1.38
Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease. Dig Dis Sci (2014) 1.38
Influence of treatment on morphological features of mucosal inflammation. Gut (2002) 1.37
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study. BMC Musculoskelet Disord (2016) 1.36
Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol (2013) 1.34
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33
Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci (1997) 1.33
New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31
Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol (2012) 1.31
Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. Gut (1997) 1.30
Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut (1992) 1.30
Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res (2012) 1.29
Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29
Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea. Inflamm Bowel Dis (2009) 1.26
Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health (2006) 1.26
Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol (2009) 1.25
Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut (1998) 1.24
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica (2009) 1.23
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol (2011) 1.23
Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Clin Exp Immunol (1980) 1.20
Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol (2013) 1.19
The M-ANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol (2007) 1.19
Long-term results of surgical treatment for Crohn's disease of the duodenum. Ann Surg (1983) 1.17
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol (2014) 1.17
Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning. Br Med J (Clin Res Ed) (1983) 1.16
Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut (1992) 1.16
Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gastroenterol (2012) 1.16
Bone disease in patients with primary sclerosing cholangitis. Gastroenterology (2010) 1.15
Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol (2001) 1.14
A microbial signature for Crohn's disease. Gut (2017) 1.14
The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis (2007) 1.14
Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol (2008) 1.14
Are adult patients more tolerant of treatment risks than parents of juvenile patients? Risk Anal (2008) 1.13
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease. Mol Ther (2012) 1.13
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant (2015) 1.12
National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology (1979) 4.98
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods (2001) 4.25
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology (1979) 3.94
Drug-induced pancreatitis: a critical review. Gastroenterology (1980) 3.21
Putative immunodominant human immunodeficiency virus-specific CD8(+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J Virol (2000) 2.51
A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology (1980) 2.39
Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea. J Clin Invest (1968) 2.02
Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med (1980) 1.98
National Cooperative Crohn's Disease Study: adverse reactions to study drugs. Gastroenterology (1979) 1.94
Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology (1984) 1.79
Radiographic findings of the National Cooperative Crohn's Disease Study. Gastroenterology (1979) 1.77
Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology (1979) 1.68
The subtle and variable clinical expressions of gluten-induced enteropathy (adult celiac disease, nontropical sprue). An analysis of twenty-one consecutive cases. Am J Med (1970) 1.64
Biliverdin reductase of guinea pig liver. J Biol Chem (1965) 1.64
Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology (1982) 1.57
Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med (1979) 1.45
Drug-induced pancreatitis. Baillieres Clin Gastroenterol (1988) 1.42
National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology (1979) 1.40
Statistics in medical research: principles versus practices. J Lab Clin Med (1968) 1.39
Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol (1992) 1.36
Quantitative study of the pathways of triglyceride synthesis by hamster intestinal mucosa. Biochim Biophys Acta (1965) 1.32
Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med (2001) 1.32
Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest (1991) 1.29
Menetrier's disease. Spontaneous metamorphosis of giant hypertrophy of the gastric mucosa to atrophic gastritis. Gastroenterology (1967) 1.26
Fecal excretion of bile acids: a new technique for studying bile acid kinetics in patients with ileal resection. J Clin Invest (1971) 1.21
Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus. J Immunol (2001) 1.19
Patterns of bile acids and microflora in the human small intestine. I. Bile acids. Gastroenterology (1973) 1.19
The treatment of retained stones in the common bile duct with sodium cholate infusion. Gut (1974) 1.16
Alopecia areata. Immunologic studies and treatment with prednisone. Arch Dermatol (1973) 1.15
Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res (1984) 1.14
Liver disease in Australia-antigen-positive blood-donors. Lancet (1971) 1.14
On the logarithmid transformation of intestinal bacterial counts. Am J Clin Nutr (1970) 1.12
Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest (1981) 1.10
Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis (1999) 1.09
Fasting bile salt pool size and composition after ileal resection. Gastroenterology (1969) 1.08
A longitudinal study of bronchitic symptoms and spirometry in a middle-aged, male, industrial population. Am Rev Respir Dis (1973) 1.06
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology (1999) 1.05
Factors affecting plasma clearance of (14C) cholic acid in patients with cirrhosis. Clin Sci Mol Med (1973) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology (1985) 1.04
Alterations of hepatic Na+,K+-atpase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci U S A (1978) 1.03
The effect of a conjugated bile salt on oleic acid absorption in the rat. Gastroenterology (1965) 1.02
Protein starvation and the small intestine. 3. Incorporation of orally and intraperitoneally administered 1-leucine 4,5-3H into intestinal mucosal protein of protein-deprived rats. J Clin Invest (1969) 1.02
Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology (1998) 1.01
Albumin metabolism in patients with Whipple's disease. J Clin Invest (1966) 1.00
Effect of ethynylestradiol on biliary excretion of bile acids, phosphatidylcolines, and cholesterol in the bile fistula rat. J Lipid Res (1977) 0.99
Reversal by triton WR-1339 of ethynyloestradiol-induced hepatic cholesterol esterification. Biochem J (1978) 0.98
CD45RA(bright)/CD11a(bright) CD8+ T cells: effector T cells. Int Immunol (1998) 0.97
Liver dysfunction with mestranol but not with norethynodrel in a patient with Enovid-induced jaundice. Ann Intern Med (1968) 0.96
Intestinal microflora of immunoglobulin-deficient and normal human subjects. Gastroenterology (1972) 0.96
Multivariate predictors in selecting medical students. J Med Educ (1971) 0.95
Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol (1976) 0.95
Obstructive cholangitis secondary to mucus secreted by a solitary papillary bile duct tumor. Gastroenterology (1986) 0.95
Epidemiology and natural history of gallstones. Semin Liver Dis (1983) 0.94
Defective histamine release in chronic urticaria. J Clin Invest (1976) 0.93
Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. Br J Dermatol (2003) 0.93
Patterns of bile acids and microflora in the human small intestine. II. Microflora. Gastroenterology (1973) 0.93
Effects of ethinyl estradiol and phenobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion. Gastroenterology (1976) 0.92
In vivo effect of bile salts and cholestyramine on intestinal anaerobic bacteria. Gastroenterology (1975) 0.92
Contraceptive steroids increase cholesterol in bile: mechanisms of action. J Lipid Res (1987) 0.91
Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency. Gastroenterology (1977) 0.91
Plasma decay of chylomicron remnants is not affected by heparin-stimulated plasma lipolytic activity in normal fasting man. J Lipid Res (1985) 0.90
Simplified estimation of normal ranges from routine laboratory data. Clin Chim Acta (1970) 0.90
Flow cytometric enumeration of antigen-specific T lymphocytes. Cytometry A (2004) 0.90
ATP stimulates Ca2+ mobilization by a nucleotide receptor in glomerular endothelial cells. Am J Physiol (1994) 0.89
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst (1991) 0.89
Coordination of gastric and gallbladder emptying after ingestion of a regular meal. Gastroenterology (1983) 0.89
Functional aspects of vascular tenascin-C expression. J Vasc Res (1995) 0.88
Disappearance of deoxycholic acid after ileal resection. Gastroenterology (1973) 0.88
The glycosyl phosphatidylinositol anchor of human T-cadherin binds lipoproteins. Biochem Biophys Res Commun (2000) 0.88
Absorption of lactic acid from an isolated intestinal segment in the intact rat. Proc Soc Exp Biol Med (1968) 0.88
Gastroenterology-1976: good news and bad news. Presidential address. Gastroenterology (1976) 0.87
Failure of medium chain triglycerides in the treatment of persistent chylous ascites secondary to lymphosarcoma. Gastroenterology (1966) 0.87
Clinical relationships of gallstones. Lancet (1971) 0.87
The biliary tract in inflammatory bowel disease. Clin Gastroenterol (1983) 0.87
Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res (1986) 0.87
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med (1982) 0.86
The effect of temperature on cerebral metabolism and blood flow in adults during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1992) 0.85
Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients. Transplantation (1996) 0.85
Gallbladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli. J Clin Invest (1983) 0.84
RecA.oligonucleotide filaments bind in the minor groove of double-stranded DNA. Proc Natl Acad Sci U S A (1995) 0.84
Intestinal and liver lymph and lymphatics. Gastroenterology (1968) 0.84
A new approach to evaluating-problem-solving in medical students. J Med Educ (1974) 0.84
Regulation of bile acid synthesis via direct effects on the microsomal membrane. Biochemistry (1986) 0.83
Binding of bile acids by dietary fiber. Am J Clin Nutr (1978) 0.83
Allergy to insect sting. III. Allergenic cross-reactivity among the vespid venoms. J Allergy Clin Immunol (1976) 0.83
Protein starvation and the small intestine. I. The growth and morphology of the small intestine in weanling rats. Exp Mol Pathol (1968) 0.83
[Postoperative analgesia with epidural morphine after hip operations (author's transl)]. Anaesthesist (1982) 0.82
Protein starvation and the small intestine. II. Disaccharidase activities. Gastroenterology (1968) 0.82